ORAGENICS, INC. Accrued Liabilities, Current
ORAGENICS, INC. (OGEN) had Accrued Liabilities, Current of $202.83 thousand as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-03-14
- 2024-12-31: Accrued Liabilities, Current $202.83K.
- 2024-09-30: Accrued Liabilities, Current $65.66K.
- 2024-06-30: Accrued Liabilities, Current $180.96K.
- 2024-03-31: Accrued Liabilities, Current $68.77K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-12-31 | $202.83K 10-K · filed 2025-03-14 |
| 2024-09-30 | $65.66K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $180.96K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $68.77K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $222.74K 10-K · filed 2025-03-14 |
| 2023-09-30 | $45.28K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $334.44K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $488.37K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $812.86K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |